news
Event preview: Drug Discovery Week Europe
3 October 2014 | By GTCbio
From 7-10 October 2014, GTCbio will proudly present its Drug Discovery Week Europe event in the beautiful city of Dublin, Ireland...
List view / Grid view
Drug Discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
news
Allied-Bristol Life Sciences appoints Satish Jindal to lead the discovery of drug candidates from leading academic institutions
3 October 2014 | By Allied-Bristol Life Sciences
Allied-Bristol Life Sciences today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol-Myers, has been appointed to lead the company’s efforts to identify and foster development of biopharmaceutical innovations from top U.S. university research institutions...
news
Probiodrug announces its intention to launch an Initial Public Offering and listing on Euronext Amsterdam
25 September 2014 | By Probiodrug
Probiodrug AG announces its intention to raise new funds through an Initial Public Offering and listing on Euronext Amsterdam...
news
Horizon Discovery Group plc interim results for the six months ended 30 June 2014
23 September 2014 | By Horizon Discovery
Horizon Discovery Group plc announces its interim results for the six months ended 30 June 2014...
news
Curie-Cancer and Inventiva announce a partnership in epigenetics for the treatment of cancer
16 September 2014 | By Andrew Lloyd & Associates
Curie-Cancer and Inventiva announce the launch of the Epicure project, which has just received financial backing from France’s national research agency, the ANR...
news
Oxford Global’s Drug Discovery USA Congress 2014 new hot topics released & regsitration is closing soon
11 September 2014 | By Oxford Global Conferences
Oxford Global Conferences are proud to present the Drug Discovery USA Congress, taking place on 21 – 22 October at the Hyatt Boston Harbor Hotel, Boston, USA...
news
Yabao Pharmaceuticals and Changzhou Le Sun Pharmaceuticals Ltd. enter an innovative partnership to develop early-stage oncology compound
6 August 2014 | By Yabao Pharmaceutical Co, Inc
Yabao Pharmaceutical Co, Inc. announced a strategic partnership with Changzhou Le Sun Pharmaceuticals Ltd.to co-develop Le Sun's leading PLK/PI3K dual inhibitor LS-008, which currently is under pre-clinical development...
news
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
5 August 2014 | By Roche
Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark...
news
Allied Minds and Bristol-Myers Squibb form new enterprise to advance discoveries of biopharmaceutical innovations at leading U.S. academic research
4 August 2014 | By Bristol-Myers Squibb Company
Allied Minds and Bristol-Myers Squibb Company announced the formation of Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S...
article
The latest trends in lab robotics and automation
15 July 2014 | By BioStrata
For those that couldn’t attend, here is a summary of some of the interesting insights shared at ELRIG’s recent Robotics and Automation 2014 Conference.
news
Domainex reports success of its lead compound in pre-clinical model of COPD and secures £1.4m Biomedical Catalyst Award
9 July 2014 | By Domainex
Domainex Ltd announced that its lead compound has demonstrated a more potent effect in a key model of chronic obstructive pulmonary disease than either roflumulast or a p38 inhibitor...
news
Fraunhofer IME integrates European ScreeningPort to enhance its expertise and capabilities in drug discovery
9 July 2014 | By Fraunhofer IME
The operative business of European ScreeningPort GmbH has been integrated into the Fraunhofer Institute for Molecular Biology and Applied Ecology IME located in Aachen...
news
Drug Discovery Conversations: Brian Pollok, Entrepreneur-in-Residence, University of Virginia
7 July 2014 | By Oxford Global
Oxford Global Q&A Session with Brian Pollok, Entrepreneur-In-Residence, University of Virginia...
news
MRC Technology and AstraZeneca renew collaboration to identify novel targets for discovery research
3 July 2014 | By MRC Technology
Initiative brings together global expertise to share compound libraries and streamline drug discovery...
news
Oxford Global’s inaugural Drug Discovery USA Congress – Hot topics announced
16 June 2014 | By Oxford Global
After the continued success of the European Drug Discovery Summit Series, Oxford Global are pleased to announce the first Drug Discovery USA Congress...
